Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Reference62 articles.
1. Hanayneh
S, Panna ME, Miles WM, Goel R. Anti-arrhythmic Drugs—a Review and Comment on Relevance in the Current Era: Part 1. Current Treatment Options in
Cardiovascular Medicine. 2021;23(9). https://doi.org/10.1007/s11936-021-00940-3.
2. Zimetbaum P. Antiarrhythmic drug therapy for atrial fibrillation. Circulation. 2012;125(2):381–9. https://doi.org/10.1161/CIRCULATIONAHA.111.019927.
3. Alpert JS, Calkins H, Joaquin Cigarroa zE, Joseph Cleveland Jr FC, Jamie Conti FB, Ellinor PT, et al. 2014 AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society 2014. Report No.: 64.
4. Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA/ACC/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heath. J Am Coll Cardiol. 2018;72(14):e91–220. https://doi.org/10.1016/j.jacc.2017.10.054.
5. Hofmann R, Steinwender C, Kammler J, Kypta A, Leisch F. Effects of a high dose intravenous bolus amiodarone in patients with atrial fibrillation and a rapid ventricular rate. Int J Cardiol. 2006;110(1):27–32. https://doi.org/10.1016/j.ijcard.2005.06.048.